Crédit Agricole
12 place des États-Unis, Montrouge, Ile-de-France, 92547, France
Overview
Credit Agricole is a universal banking corporation active with focuses on corporate and investment banking, retail banking, insurance, consumer finance and savings management. Crédit Agricole Group is serving 54 million customers (Individuals, farmers, small businesses, local authorities, institutions, corporates) across 46 countries Crédit Agricole is : - Number 1 provider of financing to the French economy (Internal source: ECO 2023) - Number 1 European asset manager with its subsidiary Amundi (Source: IPE “Top 500 Asset Managers”, June 2023) - Number 1 insurer in France (Source: L’Argus de l’assurance, 13 December 2023 - data at end-2022) - Number 1 retail bank in the European Union based on number of customers - 9th largest global bank by balance sheet size (Source: The Banker 2024) Crédit Agricole Group supports its customers in their plans and projects in France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.
- Total investments
- 38
- Lead investments
- 7
- Investments · 12mo
- 12
- Active investors
- 9
Sector focus
- Banking
- Consumer Lending
- Finance
- Insurance
- Retail
Investment portfolio
- Brenus Pharma
Participated · Series A · Jul 2026
Brenus Pharma is advancing an off-the-shelf platform in immuno-oncology that mimics tumor protein expression to make tumors visible to the immune system. Its lead clinical-stage asset is STC-1010 (NCT06934538), targeting MSS metastatic colorectal cancer, and recent execution across clinical, regulatory and business development milestones has been highlighted by the company. Brenus positions its technology for multi-asset expansion and plans to use new capital to complete the Phase I program for STC-1010 and to advance its next drug candidate. The company has raised a total of €38 million since inception following the €11 million Series A extension. The firm announced the financing from Lyon, France and continues engaging both existing and new international investors to support its development plans.
- HR Path
Led · Debt Financing · Jul 2026
HR Path provides HR software and services to enterprise clients. The company reported current revenue of about €360 million and has set a target of reaching €700 million in revenue within three years. Management said the firm plans to expand geographically into the Nordic countries and the Middle East. The recent financing and Ardian’s equity investment are intended to fund a buy-and-build strategy of acquisitions and integrations. HR Path secured a mix of senior term debt and a revolving credit facility to support both larger transactions and smaller, bridge needs. The articles do not provide further operational metrics or historical financing details.
- Bohr Énergie
Participated · Series A · Jul 2026
Founded in 2020 in Toulouse, Bohr Énergie operates a proprietary platform that combines software, AI, algorithms, production forecasting, market analysis and regulatory expertise to enable optimisation and commercialisation of distributed renewable and flexible assets. As an independent aggregator it manages solar, wind, hydro, batteries and hybrid systems, enabling asset owners to participate in electricity markets. The firm currently has more than 170 renewable and flexible assets in its portfolio and expects to reach close to 1 GW under management by the end of the year. Management plans to use the Series A capital to consolidate its French position, accelerate platform development and launch additional services. Bohr has signalled international expansion with Spain and Italy among its priority markets.
- Losanje
Participated · Equity · May 2026
Founded in 2020 and based in Nevers, Losanje designs and produces clothing made from recovered materials through upcycling. The company has invested prior proceeds into R&D and the deployment of an industrial tool to support production. With a recent €6.7 million raise on top of a €2.7 million 2023 round, Losanje is targeting consolidation and structuring of its value chain. Management aims to use the new funding to enable large-scale production projects for partner brands. The articles do not provide revenue, user metrics, or details on investors.
- Cap atlas
Participated · Equity · Apr 2026
Cap atlas specialises in acquisition and analysis of geospatial data collected by drones and develops a cartographic application called Tesseract. The company is headquartered in Ganzeville. It recently raised €1.1M to scale its operations, continue product development and speed up the commercial rollout of Tesseract. The round brought in regional investors including Normandie Participations, Normandie Littoral and Normandie Business Angels alongside historical partner Crédit Agricole Innove en Normandie. The financing is intended to help the company change scale and accelerate market development.